The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Antisense therapy for cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“Following specific receptor stimulation and dimerization, activation of the Janus tyrosine kinases or SRC family members results in the phosphorylation and activation of STAT family member”
BackgroundInsulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Bcl-2 and the regulation of programmed cell death
Reed, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.1 · Cited by 2,305
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
X-linked IAP is a direct inhibitor of cell-death proteases
Deveraux, Q. L., Takahashi, R., Salvesen, G. S., & Reed, J. C. (1997) · Nature · doi:10.1038/40901 · Cited by 1,955
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Tamm, I., Wang, Y., Sausville, E. A., Scudiero, D. A., Vigna, N. J., Oltersdorf, T., & Reed, J. C. (1998) · PubMed · Cited by 1,244
Buettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,185
Tsujimoto, Y., & Croce, C. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5214 · Cited by 1,106
McDonnell, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C. J., Chung, L. W. K., Hsieh, J., Tu, S., & Campbell, M. L. (1992) · PubMed · Cited by 1,049
Pathways of apoptotic and non-apoptotic death in tumour cells
Okada, H., & Mak, T. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1412 · Cited by 1,044
The inhibitors of apoptosis (IAPs) and their emerging role in cancer
LaCasse, E. C., Baird, S., Korneluk, R. G., & MacKenzie, A. E. (1998) · Oncogene · doi:10.1038/sj.onc.1202569 · Cited by 982
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Regulation of protein kinase C
Newton, A. C. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80058-0 · Cited by 914
Survivin, versatile modulation of cell division and apoptosis in cancer
Altieri, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207113 · Cited by 900
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
Miyashita, T., & Reed, J. (1993) · Blood · doi:10.1182/blood.v81.1.151.151 · Cited by 882
RNAi-mediated pathways in the nucleus
Matzke, M. A., & Birchler, J. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1500 · Cited by 844
Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., & Freier, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85268-7 · Cited by 778
Self-citationLNA (Locked Nucleic Acid): High-Affinity Targeting of Complementary RNA and DNA
Vester, B., & Wengel, J. (2004) · Biochemistry · doi:10.1021/bi0485732 · Cited by 727
STAT proteins: novel molecular targets for cancer drug discovery
Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1204086 · Cited by 643
Epling-Burnette, P. K., Liu, J. H., Catlett-Falcone, R., Turkson, J., Oshiro, M., Kothapalli, R., Li, Y., Wang, J.-M., Yang-Yen, H.-F., Karras, J., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9940 · Cited by 633
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., & Altieri, D. C. (1999) · Nature Cell Biology · doi:10.1038/70242 · Cited by 600
Bernardo, A., Ball, C., Nolasco, L., Moake, J. F., & Dong, J.-F. (2004) · Blood · doi:10.1182/blood-2004-01-0107 · Cited by 588
Biological and Clinical Implications of Heat Shock Protein 27000 (Hsp27): a Review
Ciocca, D. R., Oesterreich, S., Chamness, G. C., MCGuire, W. L., & Fuqua, S. A. W. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.19.1558 · Cited by 542
Raffo, A. J., Perlman, H., Chen, M., Day, M. L., Streitman, J., & Buttyan, R. (1995) · PubMed · Cited by 542
Mora, L. B., Buettner, R., Seigne, J. D., Diaz, J. I., Ahmad, N., Garcia, R., Bowman, T. L., Falcone, R., Fairclough, R., Cantor, A. B., et al. (2002) · PubMed · Cited by 533
On the role of Hsp27 in regulating apoptosis
Concannon, C. G., Gorman, A. M., & Samali, A. (2003) · Apoptosis · doi:10.1023/a:1021601103096 · Cited by 513
Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice
Schimmer, A. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1918 · Cited by 512
Lu, C., Altieri, D. C., & Tanigawa, N. (1998) · PubMed · Cited by 501
HSP27 inhibits cytochrome c‐dependent activation of procaspase‐9
Garrido, C., Bruey, J., Fromentin, A., Hammann, A., Patrick Arrigo, A., & Solary, E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.2061 · Cited by 500
BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
Webb, A., Cunningham, D., Cotter, F., Clarke, P., Di Stefano, F., Ross, P., Corbo, M., & Dziewanowska, Z. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11103-x · Cited by 489
Chemosensitisation of malignant melanoma by BCL2 antisense therapy
Jansen, B., Wacheck, V, Heere-Ress, E., Schlagbauer-Wadl, H., Hoeller, C., Lucas, T., Hoermann, M., Hollenstein, U., Wolff, K., & Pehamberger, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03207-4 · Cited by 482
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
Jansen, B., Schlagbauer-Wadl, H., Brown, B. D., Bryan, R. N., Van Elsas, A., Müller, M., Wolff, K., Eichler, H.-G., & Pehamberger, H. (1998) · Nature Medicine · doi:10.1038/nm0298-232 · Cited by 481
Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
Kyprianou, N., English, H. F., & Isaacs, J. T. (1990) · PubMed · Cited by 478
Molecular chaperones and the cytoskeleton
Liang, P., & MacRae, T. H. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.13.1431 · Cited by 461
Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins
Humphreys, D. T., Carver, J. A., Easterbrook-Smith, S. B., & Wilson, M. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.6875 · Cited by 455
Waters, J. S., Webb, A., Cunningham, D., Clarke, P. A., Raynaud, F., di Stefano, F., & Cotter, F. E. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1812 · Cited by 454
Monia, B. P., Johnston, J. F., Geiger, T., Muller, M., & Fabbro, D. (1996) · Nature Medicine · doi:10.1038/nm0696-668 · Cited by 447
Self-citationLevin, A. A. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00140-2 · Cited by 438
Hsp27 as a Negative Regulator of Cytochrome c Release
Paul, C., Manero, F., Gonin, S., Kretz-Remy, C., Virot, S., & Arrigo, A.-P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.816-834.2002 · Cited by 437
Derenne, S., Monia, B., Dean, N. M., Taylor, J. K., Rapp, M.-J., Harousseau, J.-L., Bataille, R., & Amiot, M. (2002) · Blood · doi:10.1182/blood.v100.1.194 · Cited by 427
Self-citationA public database for gene expression in human cancers.
Lal, A., Lash, A., Altschul, S. F., Velculescu, V. E., Zhang, L., McLendon, R. E., Marra, M. A., Prange, C. K., Morin, P. J., Polyák, K., et al. (1999) · PubMed · Cited by 414
Nylandsted, J., Rohde, M., Brand, K., Bastholm, L., Elling, F., & Jäättelä, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7871 · Cited by 393
Clusterin is a secreted mammalian chaperone
Wilson, M. R., & Easterbrook-Smith, S. B. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01534-0 · Cited by 378
A Critical Role for Stat3 Signaling in Immune Tolerance
Cheng, F., Wang, H.-W., Cuenca, A., Huang, M., Ghansah, T., Brayer, J., Kerr, W. G., Takeda, K., Akira, S., Schoenberger, S. P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00232-2 · Cited by 377
Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford, P. A., Dodson, A. R., PARSONS, K. F., DESMOND, A. D., Woolfenden, A., Fordham, M., Neoptolemos, J. P., Ke, Y., & Foster, C. S. (2000) · PubMed · Cited by 365
Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways
Parcellier, A., Gurbuxani, S., Schmitt, E., Solary, E., & Garrido, C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00623-5 · Cited by 359
Bubendorf, L., Kolmer, M., Kononen, J., Koivisto, P., Mousses, S., Chen, Y., Mahlamaki, E., Schraml, P., Moch, H., Willi, N., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.20.1758 · Cited by 350
Determination of the Role of the Human RNase H1 in the Pharmacology of DNA-like Antisense Drugs
Wu, H., Lima, W. F., Zhang, H., Fan, A., Sun, H., & Crooke, S. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311683200 · Cited by 349
Zhou, P., Qian, L., Kozopas, K. M., & Craig, R. W. (1997) · Blood · doi:10.1182/blood.v89.2.630 · Cited by 326
Rocchi, P., So, A., Kojima, S., Signaevsky, M., Beraldi, E., Fazli, L., Hurtado-coll, A., Yamanaka, K., & Gleave, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3998 · Cited by 316
Self-citationVargas-Roig, L. M., Gago, F. E., Tello, O., Aznar, J. C., & Ciocca, D. R. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981023)79:5<468::aid-ijc4>3.0.co;2-z · Cited by 302
Geldanamycin as a Potential Anti-Cancer Agent: Its Molecular Target and Biochemical Activity
Neckers, L., Schulte, T. W., & Mimnaugh, E. (1999) · Investigational New Drugs · doi:10.1023/a:1006382320697 · Cited by 301
Bae, J., Leo, C. P., Hsu, S. Y., & Hsueh, A. J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909826199 · Cited by 289
Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats
Geary, R. S., Watanabe, T. A., Truong, L., Freier, S., Lesnik, E. A., Sioufi, N. B., Sasmor, H., Manoharan, M., & Levin, A. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38831-7 · Cited by 288
Sigalas, I., Calvert, A. H., Anderson, J. J., Neal, D. E., & Lunec, J. (1996) · Nature Medicine · doi:10.1038/nm0896-912 · Cited by 268
Ways, D. K., Kukoly, C. A., deVente, J., Hooker, J. L., Bryant, W. O., Posekany, K. J., Fletcher, D. J., Cook, P. P., & Parker, P. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117872 · Cited by 266
Androgen‐repressed messages in the rat ventral prostate
Montpetit, M. L., Lawless, K. R., & Tenniswood, M. (1986) · The Prostate · doi:10.1002/pros.2990080105 · Cited by 258
Apolipoprotein J (clusterin) and Alzheimer's disease
Calero, M., Rostagno, A., Matsubara, E., Zlokovic, B., Frangione, B., & Ghiso, J. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000815)50:4<305::aid-jemt10>3.0.co;2-l · Cited by 256
HSP27 and HSP70: Potentially Oncogenic Apoptosis Inhibitors
Garrido, C., Schmitt, E., Candé, C., Vahsen, N., Parcellier, A., & Kroemer, G. (2003) · Cell Cycle · doi:10.4161/cc.2.6.521 · Cited by 252
Overexpression of Clusterin in Human Breast Carcinoma
Redondo, M., Villar, E., Torres-Muñoz, J., Tellez, T., Morell, M., & Petito, C. K. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64552-x · Cited by 243
Dean, N. M., & McKay, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11762 · Cited by 242
HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs.
Garrido, C., Ottavi, P., Fromentin, A., Hammann, A., Arrigo, A., Chauffert, B., & Mehlen, P. (1997) · PubMed · Cited by 241
Antisense oligonucleotide-based therapeutics for cancer
Dean, N. M., & Bennett, C. F. (2003) · Oncogene · doi:10.1038/sj.onc.1207231 · Cited by 234
Miyake, H., Nelson, C. C., Rennie, P. S., & Gleave, M. E. (2000) · PubMed · Cited by 223
Self-citationConcannon, C. G., Orrenius, S., & Samali, A. (2001) · Gene Expression · doi:10.3727/000000001783992605 · Cited by 222
Hu, Y., Cherton-Horvat, G., Dragowska, V., Baird, S. D., Korneluk, R. G., Durkin, J. P., Mayer, L. D., & LaCasse, E. C. (2003) · PubMed · Cited by 220
Sensibar, J. A., Sutkowski, D. M., Raffo, A. J., Buttyan, R., Griswold, M. D., Sylvester, S. R., Kozlowski, J. M., & Lee, C. (1995) · PubMed · Cited by 219
Specific Inhibition of PTEN Expression Reverses Hyperglycemia in Diabetic Mice
Butler, M., McKay, R. A., Popoff, I. J., Gaarde, W. A., Witchell, D., Murray, S. F., Dean, N. M., Bhanot, S., & Monia, B. P. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1028 · Cited by 216
Self-citationJuly, L. V., Akbari, M., Zellweger, T., Jones, E. C., Goldenberg, S. L., & Gleave, M. E. (2002) · The Prostate · doi:10.1002/pros.10047 · Cited by 213
Self-citationChen, J., Wu, W., Tahir, S. K., Kroeger, P. E., Rosenberg, S. H., Cowsert, L. M., Bennett, F., Krajewski, S., Krajewska, M., Welsh, K., et al. (2000) · Neoplasia · doi:10.1038/sj.neo.7900091 · Cited by 207
Trougakos, I. P., So, A., Jansen, B., Gleave, M. E., & Gonos, E. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2664 · Cited by 206
Self-citationStress-induced transcription of the clusterin/apoJ gene
MICHEL, D., CHATELAIN, G., NORTH, S., & BRUN, G. (1997) · Biochemical Journal · doi:10.1042/bj3280045 · Cited by 194
Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer.
Steinberg, J. J., Oyasu, R., Lang, S., Sintich, S. M., RADEMAKER, A. W., Lee, C., Kozlowski, J. M., & Sensibar, J. A. (1997) · PubMed · Cited by 193
Zhang, Z., Li, M., Wang, H., Agrawal, S., & Zhang, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934692100 · Cited by 192
Chi, K. N., Gleave, M. E., Klasa, R. J., Murray, N., Bryce, C. J., de Menezes, D. E. L., D’Aloisio, S., & Tolcher, A. W. (2001) · PubMed · Cited by 191
Self-citationMapping of RNA accessible sites for antisense experiments with oligonucleotide libraries
Ho, S. P., Bao, Y., Lesher, T., Malhotra, R., Ma, L. Y., Fluharty, S. J., & Sakai, R. R. (1998) · Nature Biotechnology · doi:10.1038/nbt0198-59 · Cited by 186
Wellmann, A., Thieblemont, C., Pittaluga, S., Sakai, A., Jaffe, E. S., Siebert, P., & Raffeld, M. (2000) · Blood · doi:10.1182/blood.v96.2.398 · Cited by 185
Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice.
Carpentier, A. F., Chen, L., Maltonti, F., & Delattre, J. (1999) · PubMed · Cited by 185
Gleave, M. E., Tolcher, A. W., Miyake, H., Nelson, C. C., Brown, R. E., Beraldi, E., & Goldie, J. H. (1999) · PubMed · Cited by 175
Self-citationNemunaitis, J., Holmlund, J. T., Kraynak, M., Richards, D., Bruce, J., Ognoskie, N., Kwoh, T. J., Geary, R., Dorr, A., Von Hoff, D., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3586 · Cited by 173
Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.
Lebedeva, I. V., Rando, R. F., Ojwang, J. O., Cossum, P. A., & Stein, C. A. (2000) · PubMed · Cited by 171
Geary, R. S., Yu, R. Z., Watanabe, T., Henry, S. P., Hardee, G. E., Chappell, A., Matson, J., Sasmor, H., Cummins, L., & Levin, A. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1419 · Cited by 162
Immunohistochemical Analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 Expression in Pancreatic Cancers
Miyamoto, Y., Hosotani, R., Wada, M., Lee, J.-U., Koshiba, T., Fujimoto, K., Tsuji, S., Nakajima, S., Doi, R., Kato, M., et al. (1999) · Oncology · doi:10.1159/000011933 · Cited by 158
Miyake, H., Chi, K. N., & Gleave, M. E. (2000) · PubMed · Cited by 150
Self-citationYuen, A. R., Halsey, J., Fisher, G. A., Holmlund, J. T., Geary, R. S., Kwoh, T. J., Dorr, A., & Sikic, B. I. (1999) · PubMed · Cited by 148
Kyprianou, N., King, E. D., Bradbury, D., & Rhee, J. G. (1997) · International Journal of Cancer · Cited by 147
Silke, J., Hawkins, C. J., Ekert, P. G., Chew, J., Day, C. L., Pakusch, M., Verhagen, A. M., & Vaux, D. L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108085 · Cited by 147
Zellweger, T., Chi, K., Miyake, H., Adomat, H. H., Kiyama, S., Skov, K. A., & Gleave, M. E. (2002) · PubMed · Cited by 147
Self-citationMiyake, H., Nelson, C., Rennie, P. S., & Gleave, M. E. (2000) · Endocrinology · doi:10.1210/endo.141.6.7520 · Cited by 146
Self-citationGautschi, O. P., Tschopp, S., Olie, R. A., Leech, S. H., Simões‐Wüst, A. P., Ziegler, A., Baumann, B., Odermatt, B. F., Hall, J., Stahel, R. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.6.463 · Cited by 145
Miyake, H., Pollak, M., & Gleave, M. E. (2000) · PubMed · Cited by 144
Self-citationPhase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.
Bishop, M. R., Iversen, P. L., Bayever, E., Sharp, J. G., Greiner, T. C., Copple, B. L., Ruddon, R., Zon, G., Spinolo, J., Arneson, M., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1320 · Cited by 136
Zellweger, T., Miyake, H., Cooper, S. R., Chi, K., Conklin, B., Monia, B. P., & Gleave, M. E. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29459-3 · Cited by 133
Self-citationMiyake, H., Tolcher, A. W., & Gleave, M. E. (1999) · PubMed · Cited by 132
Self-citationJuly, L. V., Beraldi, E., So, A., Fazli, L., Evans, K. G., English, J. C., & Gleave, M. E. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.223.3.3 · Cited by 132
Self-citationStevenson, J. P., Yao, K.-S., Gallagher, M., Friedland, D. P., Mitchell, E. P., Cassella, A., Monia, B. P., Kwoh, T. J., Yu, R. Z., Holmlund, J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2227 · Cited by 129
Self-citationZellweger, T., Miyake, H., July, L. V., Akbari, M., Kiyama, S., & Gleave, M. E. (2001) · Neoplasia · doi:10.1038/sj.neo.7900174 · Cited by 126
Self-citationCunningham, C. C., Holmlund, J., Schiller, J. H., Geary, R. S., Kwoh, T. J., Dorr, A., & Nemunaitis, J. J. (2000) · PubMed · Cited by 126
Tolcher, A. W., Reyno, L. M., Venner, P. M., Ernst, S., Moore, M. J., Geary, R. S., Chi, K., Hall, S. R. R., Walsh, W., Dorr, A., et al. (2002) · PubMed · Cited by 119
12(S)-HETE Enhancement of Prostate Tumor Cell Invasion: Selective Role of PKC
Liu, B., Maher, R. J., Hannun, Y. A., Porter, A. T., & Honn, K. V. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.15.1145 · Cited by 116
Kiyama, S., Morrison, K. B., Zellweger, T., Akbari, M., Cox, M., Yu, D., Miyake, H., & Gleave, M. E. (2003) · PubMed · Cited by 115
Self-citationArts, H. J. G., Hollema, H., Lemstra, W., Willemse, P. H. B., de Vries, E. G. E., Kampinga, H. H., & van der Zee, A. G. J. (1999) · International Journal of Cancer · Cited by 115
Direct Transactivation of the Anti-apoptotic Gene Apolipoprotein J (Clusterin) by B-MYB
Cervellera, M. N., Raschellà, G., Santilli, G., Tanno, B., Ventura, A., Mancini, C., Sevignani, C., Calabretta, B., & Sala, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002055200 · Cited by 112
Functional analysis of the human MCL-1 gene
Akgul, C., Turner, P. C., White, M., & Edwards, S. W. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000728 · Cited by 109
Eder, I. E., Hoffmann, J., Rogatsch, H., Schäfer, G., Zopf, D., Bartsch, G. H., & Klocker, H. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700416 · Cited by 107
Ratajczak, M. Z., Hijiya, N., Catani, L., DeRiel, K., Luger, S. M., McGlave, P. B., & Gewirtz, A. (1992) · Blood · doi:10.1182/blood.v79.8.1956.1956 · Cited by 105
Clusterin: A Role in Cell Survival in the Face of Apoptosis?
Koch-Brandt, C., & Morgans, C. W. (1996) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-79850-4_8 · Cited by 104
Davis, A. J., Gelmon, K. A., Siu, L. L., Moore, M. J., Britten, C. D., Mistry, N., Klamut, H. J., D’Aloisio, S., MacLean, M., Wainman, N., et al. (2003) · Investigational New Drugs · doi:10.1023/a:1022976528441 · Cited by 102
Do heat shock proteins have a role in breast cancer?
Conroy, S., & Latchman, D. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.427 · Cited by 99
MCL-1 expression in B-cell non-Hodgkin’s lymphomas
Cho‐Vega, J. H., Rassidakis, G. Z., Admirand, J. H., Oyarzo, M. P., Ramalingam, P., Paraguya, A., McDonnell, T. J., Amin, H. M., & Medeiros, L. J. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.04.018 · Cited by 97
Induction of apoptosis in lung-cancer cells followingbcl-xL anti-sense treatment
Leech, S. H., Olie, R. A., Gautschi, O. P., Sim�es-W�st, A. P., Tschopp, S., H�ner, R., Hall, J., Stahel, R. A., & Zangemeister‐Wittke, U. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000515)86:4<570::aid-ijc20>3.0.co;2-t · Cited by 96
Swannie, H., & Kaye, S. B. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0046-7 · Cited by 89
Adjei, A. A., Dy, G. K., Erlichman, C., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P. J., et al. (2003) · PubMed · Cited by 88
Stull, R. A., Taylor, L. A., & Szoka, F. C. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.13.3501 · Cited by 87
Heere‐Ress, E., Thallinger, C., Lucas, T., Schlagbauer‐Wadl, H., Wacheck, V., Monia, B. P., Wolff, K. S., Pehamberger, H., & Jansen, B. (2002) · International Journal of Cancer · doi:10.1002/ijc.10248 · Cited by 85
Self-citationInhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma
Ansell, S. M., Arendt, B. K., Grote, D. M., Jelinek, D. F., Novak, A. J., Wellik, L. E., Remstein, E. D., Bennett, C. F., & Fielding, A. K. (2004) · Leukemia · doi:10.1038/sj.leu.2403281 · Cited by 84
Matveeva, O. V. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.24.5010 · Cited by 82
Henry, S. P., Geary, R. S., Yu, R. Z., & Levin, A. A. (2001) · PubMed · Cited by 79
Wang, H., Yu, D., Agrawal, S., & Zhang, R. (2003) · The Prostate · doi:10.1002/pros.10187 · Cited by 78
Han, Z., Chatterjee, D., Early, J., Pantazis, P., Hendrickson, E. A., & Wyche, J. H. (1996) · PubMed · Cited by 72
Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas
Parczyk, K., Pilarsky, C. P., Rachel, U., & Koch-Brandt, C. (1994) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01202200 · Cited by 70
Gill, P. K., Gescher, A. J., & Gant, T. W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02326.x · Cited by 65
bcl-xl antisense treatment induces apoptosis in breast carcinoma cells
Simões‐Wüst, A. P., Olie, R. A., Gautschi, O. P., Leech, S. H., Häner, R., Hall, J., Fabbro, D., Stahel, R. A., & Zangemeister‐Wittke, U. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000815)87:4<582::aid-ijc19>3.0.co;2-p · Cited by 64
Shen, L., Dean, N. M., & Glazer, R. I. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12039-1 · Cited by 64
Henry, S. P., Monteith, D., & Levin, A. A. (1997) · PubMed · Cited by 62
Geiger, T. M., Müller, M., Dean, N. M., & Fabbro, D. (1998) · PubMed · Cited by 58
Mcl-1 Is a Novel Therapeutic Target for Human Sarcoma
Thallinger, C., Wolschek, M. F., Maierhofer, H., Skvara, H., Pehamberger, H., Monia, B. P., Jansen, B., Wacheck, V., & Selzer, E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0774 · Cited by 56
Self-citationWang, X., Repasky, E. A., & Liu, H.-T. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4529 · Cited by 54
Henry, S. P., Monteith, D. K. B., Bennett, F., et al. (1997) · PubMed · Cited by 48
Bcl-2 antisense therapy in B-cell malignancies
Chanan-Khan, A. A. (2005) · Blood Reviews · doi:10.1016/j.blre.2004.11.002 · Cited by 45
Second Generation Antisense Oligonucleotides: 2′-Modifications
Cook, P. D. (1998) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61096-9 · Cited by 41
Rai, K. R., Moore, J. O., Boyd, T. E., Larratt, L. M., Голенков, А. К., Koziner, B., Chanan-Khan, A. A., Bociek, R. G., & Itri, L. M. (2004) · Blood · doi:10.1182/blood.v104.11.338.338 · Cited by 37
Antisense Therapy: Current Status in Prostate Cancer and Other Malignancies
Gleave, M. E., Miyake, H., Zangemeister‐Wittke, U., & Jansen, B. (2002) · Cancer and Metastasis Reviews · doi:10.1023/a:1020172424152 · Cited by 35
Self-citationBiroccio, A., D’Angelo, C., Jansen, B., Gleave, M. E., & Zupi, G. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20295 · Cited by 34
Self-citationAssay for Evaluating Ribonuclease H-Mediated Degradation of RNA–Antisense Oligonucleotide Duplexes
Galarneau, A., Min, K., Mangos, M., & Damha, M. J. (2004) · Humana Press eBooks · doi:10.1385/1-59259-823-4:065 · Cited by 10
Cited by
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
RetractedPromoting apoptosis as a strategy for cancer drug discovery
Fesik, S. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1736 · Cited by 1,098
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D., & Trent, J. O. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.004 · Cited by 874
MicroRNAs — the micro steering wheel of tumour metastases
Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S., & Calin, G. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2619 · Cited by 749
Metadata
- Authors
- Gleave, M. E., & Monia, B. P.
- Venue
- Nature Reviews Cancer
- Published
- 2005-05-20
- Volume
- 5
- Issue
- 6
- Pages
- 468-479
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1990507217
- Cited by
- 384
- References
- 143
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.